A citation-based method for searching scientific literature

Donghyuk Shin, Rukmini Mukherjee, Diana Grewe, Denisa Bojkova, Kheewoong Baek, Anshu Bhattacharya, Laura Schulz, Marek Widera, Ahmad Reza Mehdipour, Georg Tascher, Paul P Geurink, Alexander Wilhelm, Gerbrand J van der Heden van Noort, Huib Ovaa, Stefan Müller, Klaus-Peter Knobeloch, Krishnaraj Rajalingam, Brenda A Schulman, Jindrich Cinatl, Gerhard Hummer, Sandra Ciesek, Ivan Dikic. Nature 2020
Times Cited: 408



Wenhao Dai, Bing Zhang, Xia-Ming Jiang, Haixia Su, Jian Li, Yao Zhao, Xiong Xie, Zhenming Jin, Jingjing Peng, Fengjiang Liu, Chunpu Li, You Li, Fang Bai, Haofeng Wang, Xi Cheng, Xiaobo Cen, Shulei Hu, Xiuna Yang, Jiang Wang, Xiang Liu, Gengfu Xiao, Hualiang Jiang, Zihe Rao, Lei-Ke Zhang, Yechun Xu, Haitao Yang, Hong Liu. Science 2020
Times Cited: 675




List of shared articles



Times cited

Interfering with the Reactive Cysteine Proteome in COVID-19.
Marcos Martinez-Banaclocha. Curr Med Chem 2022
1

Promising Enzymes for Inhibitors Development Against COVID-19.
Zhi-Gang Sun, Feng-Ling Yu, Xiang-Ting Qiu, Shuang Li, Xue-Tang Li, Hai-Liang Zhu. Mini Rev Med Chem 2022
0

Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors.
Shenghua Gao, Tianguang Huang, Letian Song, Shujing Xu, Yusen Cheng, Srinivasulu Cherukupalli, Dongwei Kang, Tong Zhao, Lin Sun, Jian Zhang,[...]. Acta Pharm Sin B 2022
7

Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors.
Sarah Huff, Indrasena Reddy Kummetha, Shashi Kant Tiwari, Matthew B Huante, Alex E Clark, Shaobo Wang, William Bray, Davey Smith, Aaron F Carlin, Mark Endsley,[...]. J Med Chem 2022
12

Repurposing the antibacterial drugs for inhibition of SARS-CoV2-PLpro using molecular docking, MD simulation and binding energy calculation.
Rohit Patel, Jignesh Prajapati, Priyashi Rao, Rakesh M Rawal, Meenu Saraf, Dweipayan Goswami. Mol Divers 2022
3

Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L.
Anneliese S Ashhurst, Arthur H Tang, Pavla Fajtová, Michael C Yoon, Anupriya Aggarwal, Max J Bedding, Alexander Stoye, Laura Beretta, Dustin Pwee, Aleksandra Drelich,[...]. J Med Chem 2022
9

Computational anti-COVID-19 drug design: progress and challenges.
Jinxian Wang, Ying Zhang, Wenjuan Nie, Yi Luo, Lei Deng. Brief Bioinform 2022
0

Targeted protein degradation: from small molecules to complex organelles-a Keystone Symposia report.
Jennifer Cable, Eilika Weber-Ban, Tim Clausen, Kylie J Walters, Michal Sharon, Daniel J Finley, Yangnan Gu, John Hanna, Yue Feng, Sascha Martens,[...]. Ann N Y Acad Sci 2022
0

Structure-based identification of naphthoquinones and derivatives as novel inhibitors of main protease Mpro and papain-like protease PLpro of SARS-CoV-2.
Lucianna H Santos, Thales Kronenberger, Renata G Almeida, Elany B Silva, Rafael E O Rocha, Joyce C Oliveira, Luiza V Barreto, Danielle Skinner, Pavla Fajtová, Miriam A Giardini,[...]. bioRxiv 2022
0

Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19.
Can-Rong Wu, Wan-Chao Yin, Yi Jiang, H Eric Xu. Acta Pharmacol Sin 2022
9

Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development.
Zongyang Lv, Kristin E Cano, Lijia Jia, Marcin Drag, Tony T Huang, Shaun K Olsen. Front Chem 2022
4

SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
Jiyao Chen, Zhuang Li, Jiahui Guo, Shangen Xu, Junwei Zhou, Qian Chen, Xue Tong, Dang Wang, Guiqing Peng, Liurong Fang,[...]. J Virol 2022
2

Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 Mpro.
Son Tung Ngo, Trung Hai Nguyen, Nguyen Thanh Tung, Binh Khanh Mai. RSC Adv 2022
0

Antiviral cyclic peptides targeting the main protease of SARS-CoV-2.
Jason Johansen-Leete, Sven Ullrich, Sarah E Fry, Rebecca Frkic, Max J Bedding, Anupriya Aggarwal, Anneliese S Ashhurst, Kasuni B Ekanayake, Mithun C Mahawaththa, Vishnu M Sasi,[...]. Chem Sci 2022
3

Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19.
Hong Zhou, Wei-Jian Ni, Wei Huang, Zhen Wang, Ming Cai, Yan-Cai Sun. Front Immunol 2022
2

Hydrazones and Thiosemicarbazones Targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like Protease.
Wiebke Ewert, Sebastian Günther, Francesca Miglioli, Sven Falke, Patrick Y A Reinke, Stephan Niebling, Christian Günther, Huijong Han, Vasundara Srinivasan, Hévila Brognaro,[...]. Front Chem 2022
2

Design, synthesis and docking study of Vortioxetine derivatives as a SARS-CoV-2 main protease inhibitor.
Hemant Suryavanshi, Raju D Chaudhari, Vishakha Patil, Swapan Majumdar, Sudhan Debnath, Goutam Biswas. Daru 2022
0